Article
New Approaches for Macromolecule Oral Delivery
The toolkit of technologies based upon lipid-based drug delivery systems.
View Now
Offering Fact Sheet
OptiGel Mini Technology
Deliver higher API concentrations in smaller capsules for patient benefits.
View Now
Presentation
AAPS 2014 with Pharmaceutical Outsourcing
OptiPact™ Technology, capabilities for Orphan Drugs & Catalent's factors of differentiation.
View Now
Case Study
OptiGel Bio Enables Delivery of Synthetic Oligosaccharides
Macromolecules can potentially be converted from injectable to oral drug delivery.
View Now
Article
Lipid-Based Delivery of Peptide Therapeutics
An explanation of OptiGel Bio™ technology as a delivery tool for macromolecule NCE candidates.
View Now
Presentation
Conversion from LFHS to RP Scherer Softgel Capsules
RP Scherer Technology can improve timelines and commercialization potential.
View Now
Poster
OptiShell® Technology Capsule Innovations
New shell and hot-filling that are highly viscous or semi-solid at room temperature
View Now
